Pharmaceutical News and Articles

Burger King, Other Fast Food Chains Also Pulling Onions Tied to E. Coli Outbreak

With onions from one supplier implicated as the source of E. coli illness linked to McDonald s Quarter Pounders, other fast food chains are now pulling the onio

U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease

FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy

Omeros Corporation today announced that zaltenibart (OMS906) has received rare pediatric disease designation from the U.S. Food and Drug Administration (FDA) fo

Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

Infectious Diseases Society of America, Oct. 16-19

From 1999 to 2019, there was a decrease in the sepsis-related mortality rate in children overall and across demographic groups, according to findings presented

Knowledge of Abdominal Aortic Calcification Results Improves Some CVD Risk Factors

Providing vascular imaging results does not improve diet but does improve some cardiovascular disease risk factors at 12 weeks posttest, according to a study pu

Newborn Genome Analysis Spots More Health Issues Than Standard Screening

DNA analysis of newborns can detect many more preventable or treatable health problems than standard newborn screening does, a new study shows. Genome sequencin

Protracted Radiation Exposure Linked to Hematologic Cancer Mortality

Protracted low-dose exposure to ionizing radiation among radiation-monitored workers is associated with mortality due to some hematologic malignancies, accordin

Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM

For patients with type 2 diabetes (T2D), duodenal recellularization via electroporation therapy (ReCET), which uses pulsed electric fields to induce natural cel

ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema

For adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regularly interspaced short palindromic repeats (